1. |
Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction:incidence, characteristics, and treatment strategies[J]. Gastric Cancer, 2010, 13(2):63-73.
|
2. |
張祥宏, 王其彰. 對食管胃交界腺癌的認識和爭議[J]. 中華腫瘤雜志, 2008, 12(30):947-949.
|
3. |
Tsiouris A, Hammoud Z, Velanovich V. Barrett’s esophagus afterresection of the gastroesophageal junction:effects of concomitant fundoplication[J]. World J Surg, 2011, 35(8):1867-1872.
|
4. |
Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastroesophagealjunction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status[J]. Am J Gastroenterol, 2006, 101(5):926-933.
|
5. |
Dent J. Pathogenesis and classification of cancer around the gastro-esophageal junction—not so different in Japan[J]. Am J Gastr-oenterol, 2006, 101(5):934-936.
|
6. |
楊琳, 朱玥璐, 王斌, 等. 進展期食管胃交界腺癌臨床病理分析319例[J]. 世界華人消化雜志, 2012, 20(9):784-789.
|
7. |
王龍, 劉巍, 呂雅蕾, 等. 食管胃結合部腺癌及胃癌Cox模型預后影響因素分析[J]. 中國腫瘤臨床, 2012, 39(19):1420-1425.
|
8. |
Griffiths EA, Pritchard SA, Mapstone NP, et al. Emerging aspectsof oesophageal and gastroesophageal junction cancer histopa-thology—an update for the surgical oncologist[J]. World J Surg Oncol, 2006, 4(4):82-98.
|
9. |
Koppert LB, Wijnhoven BP, Tilanus HW, et al. Neuroendocrine in barrett’s mucosa and adenocarcinomas of the gastroesophageal junction[J]. Int J Surg Pathol, 2004, 12(2):117-125.
|
10. |
Chandrasoma P, Wickramasinghe K, Ma Y, et al. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas ofthe distal esophagus, gastroesophageal junction and gastric cardia?[J]. Dis Esophagus, 2007, 20(1):36-41.
|
11. |
Chak A, Ochs-Balcom H, Falk G, et al. Familiality in barrett’s esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(9):1668-1673.
|
12. |
Gee DW, Rattner DW. Management of gastroesophageal tumors[J]. Oncologist, 2007, 12(2):175-185.
|
13. |
Lehrbach DM, Cecconello I, Ribeiro Jr U, et al. Adenocarcinoma of the esophagogastric junction:relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions[J]. Arq Gastroenterol, 2009, 46(4):315-320.
|
14. |
Gertler R, Stein HJ, Loos M, et al. How to classify adenocarcinomas of the esophagogastric junction:as esophageal or gastric cancer?[J]. Am J Surg Pathol, 2011, 35(10):1512-1522.
|
15. |
de Manzoni G, Zanoni A, Giacopuzzi S. Treatment of esophago-gastric junction adenocarcinoma[J]. Ann Ital Chir, 2012, 83(3):208-214.
|
16. |
林家威, 黃順榮, 吳東波, 等. 64排螺旋CT三期增強掃描在胃癌淋巴結清掃術前評估中的價值[J]. 世界華人消化雜志, 2012, 20(7):596-600.
|
17. |
Mönig SP, Baldus SE, Zirbes TK, et al. Lymph node size and metastatic infiltration in colon cancer[J]. Ann Surg Oncol, 1999, 6(6):579-581.
|
18. |
Fukuya T, Honda H, Hayashi T, et al. Lymph-node metastases:efficacy for detection with helical CT in patients with gastric cancer[J]. Radiology, 1995, 197(3):705-711.
|
19. |
姜波健, 吳巨鋼, 俞繼衛, 等. 胃癌淋巴管生成、淋巴管浸潤及淋巴結微轉移的臨床意義[J]. 中國普外基礎與臨床雜志, 2008, 15(12):903-909.
|
20. |
莫景雄, 黃力營. 胃癌淋巴結轉移CT分析[J]. 現代醫用影像學, 2012, 21(3):169-171.
|
21. |
王成龍, 鄭興菊, 孫家瑜, 等. MDCT對胃食管交界區癌術前TN分期及分型的診斷價值[J]. 中國普外基礎與臨床雜志, 2012, 19(4):446-451.
|
22. |
Paramo JC, Gomez G. Dynamic CT in the preoperative evaluation of patients with gastric cancer:correlation with surgical findings and pathology[J]. Ann Surg Oncol, 1999, 6(4):379-384.
|
23. |
Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction[J]. Scand J Surg, 2006, 95(4):260-269.
|
24. |
Shin SH, Jung H, Choi SH, et al. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer[J]. Ann Surg Oncol, 2009, 16(5):1304-1309.
|
25. |
Mönig SP, Collet PH, Baldus SE, et al. Splenectomy in proximal gastric cancer:frequency of lymph node metastasis to the splenic hilus[J]. J Surg Oncol, 2001, 76(2):89-92.
|